Karachi: Haleon Pakistan Limited has announced a strategic investment of £3.58 million aimed at expanding and modernizing its Panadol Liquid packaging line. The announcement was made on January 27, 2026, as part of the company's long-term growth strategy in the consumer healthcare sector.

The investment has been approved by the Board of Directors of Haleon Pakistan Limited. It will focus on acquiring advanced packaging machinery, upgrading current infrastructure, and implementing quality control enhancements. These efforts are designed to boost production capacity, improve operational efficiency, and meet the increasing market demand for Panadol Liquid products.

According to information available from the Pakistan Stock Exchange (PSX), Haleon Pakistan Limited's initiative underscores its commitment to innovation within the healthcare segment. The company’s decision aligns with its strategic objectives to strengthen its market position and address evolving consumer needs.